September 2026
The global tuberculosis diagnostics market size is calculated at USD 2.70 billion in 2026 and is projected to hit around USD 4.08 billion by 2034 with a CAGR of 5.30%.
July 2026
The U.S. tuberculosis diagnostics market size was evaluated at USD 576.00 million in 2025 and is predicted to hit around USD 968.67 million by 2035, growing at a CAGR of 5.34%.
September 2026
The rapid diagnostics market size was estimated at USD 61.75 billion in 2026 and is projected to surpass around USD 322.71 billion in 2035 with a solid CAGR of 20.23%.
September 2026
The global guillain barre syndrome diagnostics market size is estimated to hit around USD 206.70 million by 2035 increasing from USD 158.64 million in 2026, with a CAGR of 2.99%.
September 2026
The precision diagnostics market size was estimated at USD 109.84 billion in 2026, with precision diagnostics market Companies Abbott Laboratories, Bayer AG, Koninklijke Philips N.V., Lantheus Holdings Inc.
September 2026
The global PCR-based transplant diagnostics market size is estimated to hit around USD 1,286.31 million by 2035 increasing from USD 703.8 million in 2026, with a CAGR of 6.93%.
September 2026
The global advanced vehicle diagnostics and remote services market size was evaluated at USD 8.95 billion in 2026 and is predicted to hit around USD 24.28 billion by 2035, growing at a CAGR of 11.73%.
September 2026
The global food diagnostics market size is calculated at USD 20.64 billion in 2026 and is projected to hit around USD 36.75 billion by 2035 with a CAGR of 6.63%.
September 2026
The preeclampsia diagnostics market size reached USD 1.33 billion in 2026, with leading preeclampsia diagnostics market companies including Thermo Fisher Scientific, F. Hoffmann La Roche Ltd, PerkinElmer Inc.
September 2026
The global saliva collection and diagnostics market size is valued at USD 899.03 million in 2026 and is expected to hit around USD 1,363.13 million by 2035, with a CAGR of 4.73%.
September 2026
The homecare diagnostics & therapeutics market size accounted for USD 291.51 billion in 2026 and is expected to hit USD 577.56 billion by 2035, with a CAGR of 7.90%.
September 2026
The global next-generation cancer diagnostics market size is projected to hit around USD 46.43 billion by 2035 from USD 20.28 billion in 2026, with a CAGR of 9.25%.
September 2026
The global on-board diagnostics (OBD) aftermarket size is expected to hit around USD 33.97 billion by 2034 from USD 7.54 billion in 2026 with a CAGR of 20.71%.
September 2026
The global point-of-care infectious disease diagnostics market size is projected to hit around USD 25.66 billion by 2035, with a CAGR of 15.26% from 2026 to 2035.
September 2026
The global DNA diagnostics market size is accounted at USD 12.14 billion in 2026 and is projected to hit around USD 17.78 billion by 2035 with a CAGR of 4.32%.
September 2026
The infectious disease in-vitro diagnostics market size is valued at USD 28.78 billion in 2026 and is expected to hit around USD 35.68 billion by 2035, growing at a CAGR of 2.42%.
September 2026
The global non-invasive cancer diagnostics market size is projected to hit around USD 350.78 billion by 2035 from USD 185.94 billion in 2026, with a CAGR of 7.32%.
September 2026
The global home diagnostics market size accounted for USD 7.28 billion in 2026 and is expected to reach USD 11.54 billion by 2035, growing at a CAGR of 5.26%.
September 2026
The infectious respiratory disease diagnostics market size was USD 60.62 billion in 2026, with leading infectious respiratory disease diagnostics market players including F. Hoffmann - La Roche, Thermo Fisher Scientific, Danaher (Cepheid), Abbott LaboratoriesÂ
September 2026
The breast cancer diagnostics market size is valued at USD 21.78 billion in 2026 and is projected to hit around USD 43.62 billion by 2035 with a CAGR of 8.03%.
September 2026
The molecular diagnostics market size is calculated at USD 46.61 billion in 2026 and is expected to hit around USD 66.34 billion by 2035 with a CAGR of 3.93%.
September 2026
The epigenetics diagnostics market size was evaluated at USD 22.40 billion in 2026 and is predicted to worth around USD 67.26 billion by 2034, with a CAGR of 14.81%.
September 2026
The global in vitro diagnostics quality controls market size is estimated to hit around USD 2,713.92 million by 2035, increasing from USD 1,736.17 million in 2026, with a CAGR of 5.09%.
September 2026
The global HIV diagnostics market size was evaluated at USD 1.41 billion in 2026 and is predicted to hit around USD 2.24 billion by 2035, growing at a CAGR of 5.26%.
September 2026
The global transplant diagnostics market size is expected to increase from USD 5.22 billion in 2026 to hit around USD 9.24 billion by 2035, growing at a CAGR of 6.55%.
September 2026
The global point-of-care diagnostics market size is exhibited at USD 65.94 billion in 2026 and is predicted to be worth around USD 85.03 billion by 2035 with a CAGR of 2.87%.
September 2026
The global blood cancer diagnostics market size is estimated to hit around USD 22.55 billion by 2035 increasing from USD 12.46 billion in 2026, with a CAGR of 6.83%.
September 2026
The global infectious disease molecular diagnostics market size is estimated to hit around USD 63.37 billion by 2034 with a CAGR of 3.25% from 2026 to 2034.
September 2026
The global prostate cancer diagnostics market size is expected to hit around USD 18 billion by 2035 from USD 10.34 billion in 2026 , with a CAGR of 6.36%.
September 2026
The global sexually transmitted diseases diagnostics market size is estimated to hit around USD 21.44 billion by 2034 from USD 12.26 billion in 2026, with a CAGR of 7.24%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com